Recipient-specific tolerance after HLA-mismatched umbilical cord blood stem cell transplantation

Transplantation

Volumn 80, Issue 9, 2005, Pages 1316-1322

  Kleen, Thomas O ^a   Kadereit, Suzanne ^a   Fanning, Laura R ^a   Jaroscak, Jennifer ^a   Fu, Pingfu ^a   Meyerson, Howard J ^a   Kulchycki, Lara ^a   Slivka, Laura F ^a   Kozik, Margaret ^a   Tary Lehmann, Magdalena ^a   Laughlin, Mary J ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Hematopoietic stem cell transplant; Immune tolerance; Umbilical cord blood

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ADULT; ALLOIMMUNITY; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOKINE PRODUCTION; GRAFT VERSUS HOST REACTION; HLA MATCHING; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE; PRIORITY JOURNAL; RECIPIENT; TH2 CELL; UMBILICAL CORD BLOOD;

ADULT; BLOOD DONORS; BLOOD GROUP INCOMPATIBILITY; FETAL BLOOD; HLA ANTIGENS; HUMANS; INTERFERONS; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES; MIDDLE AGED; MONOCYTES; STEM CELL TRANSPLANTATION; TRANSPLANTATION TOLERANCE;

EID: 28544450411     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000188172.26531.6f     Document Type: Article

References (38)

1. Storb R. Allogeneic hematopoietic stem cell transplantation - yesterday, today, and tomorrow. Exp Hematol 2003; 31 (1): 1.
2. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. New Engl J Med 1998; 339 (22): 1565.
3. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335 (3): 157.
4. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337 (6): 373.
5. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non-malignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100 (5): 1611.
6. Passweg JR, Stern M, Koehl U, et al. Use of natural killer cells in hematopoetic stem cell transplantation. Bone Marrow Transplant 2005; 35 (7): 637.
7. Hoffmann P, Ermann J, Edinger M, et al. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002; 196 (3): 389.
8. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351 (22): 2265.
9. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344 (24): 1815.
10. Rocha V, Wagner JE, Jr., Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000; 342 (25): 1846.
11. Barker JN, Weisclorf DJ, DeFor TE, et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003; 102 (5): 1915.
12. Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351 (22): 2276.
13. Kadereit S, Kozik MM, Junge GR, et al. Cyclosporin A effects during primary and secondary activation of human umbilical cord blood T lymphocytes. Exp Hematol 2001; 29 (7): 903.
14. Kaminski BA, Kadereit S, Miller RE, et al. Reduced expression of NFAT-associated genes in UCB versus adult CD4+ T lymphocytes during primary stimulation. Blood 2003; 102 (13): 4608.
15. Risdon G, Gaddy J, Stehman FB, Broxmeyer HE. Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation. Cell Immunol 1994; 154 (1): 14.
16. Porcu P, Gaddy J, Broxmeyer HE. Alloantigen-induced unresponsiveness in cord blood T lymphocytes is associated with defective activation of Ras. Proc Natl Acad Sci U S A 1998; 95 (8): 4538.
17. Hesse MD, Karulin AY, Boehm BO, et al. A T cell clone's avidity is a function of its activation state. J Immunol 2001; 167 (3): 1353.
18. Falcioni F, Shah H, Vidovic D, et al. Influence of CD26 and integrins on the antigen sensitivity of human memory T cells. Hum Immunol 1996; 50 (2): 79.
19. Rininsland FH, Helms T, Asaad RJ, et al. Granzyme B ELISPOT assay tor ex vivo measurements of T cell immunity. J Immunol Methods 2000 240 (1-2): 143.
20. Helms T, Boehm BO, Asaad RJ, et al. Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients. J Immunol 2000; 164 (7): 3723.
21. Verdonck LF, Dekker AW, de Gast GC, et al. Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood 1994; 83 (10): 3090.
22. Heeger PS, Greenspan NS, Kuhlenschmidt S, et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163 (4): 2267.
23. Terakura S, Murata M, Nishicla T, et al. A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantation. Br J Haematol 2005; 129 (2): 221.
24. Hentschke P, Remberger M, Mattsson J, et al. Clinical tolerance after allogeneic hematopoietic stem cell transplantation: a study of influencing factors. Transplantation 2002; 73 (6): 930.
25. Laughlin MJ, Rizzieri DA, Smith CA, et al. Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia. Leuk Res 1998; 22 (3): 215.
26. Forsthuber T, Yip HC, Lehmann PV. Induction of TH1 and TH2 immunity in neonatal mice. Science 1996; 271 (5256): 1728.
27. Hussey GD, Watkins ML, Goddard EA, et al. Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies. Immunology 2002; 105 (3): 314.
28. Vekemans J, Amedei A, Ota MO, et al. Neonatal bacillus Calmette-Guerin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol 2001; 31 (5): 1531.
29. Garcia AM, Fadel SA, Cao S, Sarzotti M. T cell immunity in neonates. Immunol Res 2000; 22 (2-3): 177.
30. Siegrist CA. Vaccination in the neonatal period and early infancy. Int Rev Immunol 2000; 19 (2-3): 195.
31. Adkins B. Development of neonatal Th1/Th2 function. Int Rev Immunol 2000; 19(2-3): 157.
32. Sarzotti M, Robbins DS, Hoffman PM. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 1996; 271 (5256): 1726.
33. Chalmers IM, Janossy G, Contreras M, Navarrete C. Intracellular cytokine profile of cord and adult blood lymphocytes. Blood 1998; 92 (1): 11.
34. Klein AK, Patel DD, Gooding ME, et al. T-Cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant 2001; 7 (8): 454.
35. Salama AD, Najafian N, Clarkson MR, et al. Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 2003; 14 (6): 1643.
36. Fuller TC, Fuller A. The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder. Transplantation 1999; 68 (2): 173.
37. Baron F, Schaat-Lafontaine N, Humblet-Baron S, et al. T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation 2003; 76 (12): 1705.
38. Martinez C, Urbano-Ispizua A, Rozman C, et al. Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts. Exp Hematol 1999; 27 (3): 561.